Genomic and proteomic evidence for hormonal and metabolic foundations of polycystic ovary syndrome
Loes M E MoolhuijseniD, Jia ZhuiD, Benjamin H. MulliniD, Natàlia Pujol‐GualdoiD, Ky’Era V. ActkinsiD, Jasmine A. MackiD, Hridya RaoiD, Bhavi Trivedi, Katherine A. KentistouiD, Yajie ZhaoiD, David Westergard, Jaakko S. TyrmiiD, Guðmar ÞorleifssoniD, Yanfei ZhangiD, Laura B. L. WittemansiD, Amber A DeVriesiD, Kelly BreweriD, Ryan K. SiskiD, Rebecca Danning, Michael H PreussiD, Michelle R. JonesiD, Katherine S. RuthiD, Marianne AnderseniD, Ricardo AzziziD, Karina BanasikiD, , Felix R. DayiD
Abstract
Polycystic ovary syndrome (PCOS) and its underlying features remain poorly understood. In this genetic and proteomic study, we expand the number of genetic loci from 19 to 29, and identify 31 associated plasma proteins. Many risk-increasing loci were associated with later age at menopause, underscoring the reproductive longevity related to a larger functional ovarian reserve. Hormonal regulation in the aetiology of this condition, through metabolic and reproductive features, was emphasised. The proteomic analysis highlighted perturbations of metabolically-related biology that are typical in women with PCOS. A PCOS polygenic risk score was associated with adverse cardio-metabolic outcomes, with differing contributions of testosterone and BMI in women and men. Finally, while oligo- and anovulatory infertility are characteristic features of PCOS, we observed no impact of PCOS susceptibility on childlessness. We suggest that PCOS susceptibility confers balanced pleiotropic influences on fertility in women, and life-long adverse metabolic consequences in both sexes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sex Modifies the Effect of Genetic Risk Scores for Polycystic Ovary Syndrome on Metabolic Phenotypes
Ky’Era V. Actkins, Genevieve Jean-Pierre, … Lea Karatheodoris Davis·PLoS GeneticsPeer-reviewed·May 31, 2023
- Large-Scale Genome-Wide Meta Analysis of Polycystic Ovary Syndrome Suggests Shared Genetic Architecture for Different Diagnosis Criteria.
Felix R. Day, Tugce Karaderi, … Corrine Kolka Welt·PLoS GeneticsPeer-reviewed·Dec 19, 2018
- Understanding and Predicting Polycystic Ovary Syndrome through Shared Genetics with Testosterone, SHBG, and Chronic Inflammation
Lillian Kay Petersen, Garyk Brixi, … Liming Liang·medRxiv·Oct 17, 2023
- Phenotypic clustering reveals distinct subtypes of polycystic ovary syndrome with novel genetic associations
Matthew Dapas, Frederick T. J. Lin, … Andrea Elizabeth Dunaif·PLoS MedicinePeer-reviewed·Jun 23, 2020
- Polycystic ovary syndrome susceptibility loci inform disease etiological heterogeneity
Yanfei Zhang, Vani C. Movva, … Ming Ta Michael Lee·Journal of Clinical MedicinePeer-reviewed·Jun 18, 2021
- Metabolomic Profiling of Serum Biomarkers in Women with Polycystic Ovary Syndrome: Insights from an Untargeted Approach
Jalpa Patel, Hiral Chaudhary, … Rushikesh G. Joshi·bioRxiv·Feb 28, 2026